NetworkNewsBreaks Archive - Page 2053 of 2140

FridayMay 05, 2017 12:13 pm

NetworkNewsBreaks – National Waste Management Holdings, Inc. (NWMH) on Track to Duplicate Success of Industry Behemoth

Boasting triple-digit year-over-year revenue growth in 2016, National Waste Management Holdings (OTC: NWMH) continues its robust strategic expansion, having acquired, within a span of just over 18 months, Waste Recovery Enterprises, Gateway Rolloff Services, Sivart Services, Northeast Data Destruction & Recycling, and Burts Refuse. The company is successfully following a growth path similar to that of Wayne Huizenga, who founded Waste Management, Inc. (NYSE: WM) in the 1960s and started aggressively buying smaller waste collection services across the United States to create what is now the largest waste management company in the country. “With a focus on further strategic expansion,…

FridayMay 05, 2017 11:10 am

NetworkNewsBreaks – SinglePoint, Inc. (SING) CEO Discusses “State of the Company” in Interview on MoneyTV

Specialized holding company Singlepoint, Inc. (OTC: SING) is a featured company on this week’s episode of MoneyTV with Donald Baillargeon. MoneyTV is an internationally syndicated television program about “money and what makes it happen.” To view the show, visit www.MoneyTV.net. In this week’s episode, Singlepoint CEO Greg Lambrecht discusses the ‘State of the Company’, giving prospective shareholders some additional insight into the forward plans of both SinglePoint and its SingleSeed subsidiary. “We’re continuing to stick to our plan – that is to raise funds, acquire companies and get more products that we can sell to dispensaries,” Lambrecht noted in the…

FridayMay 05, 2017 8:58 am

NetworkNewsBreaks – ABcann Global Corporation (ABCN:CA) Appoints W. Brett Wilson to Advisory Board

In a news release issued earlier this week, ABcann Global Corporation (ABCN:CA) announced the appointment of W. Brett Wilson to its advisory board in connection with the company’s acquisition of ABcann Medicinals Inc. Wilson brings extensive experience in financing and building early stage ventures to the Abcann Global team, having previously co-founded highly-regarded investment bank FirstEnergy in 1993. He is also a recognizable television personality known for his role as a “Dragon” on CBC’s award-winning Dragon’s Den program. “Mr. Wilson is a welcome addition to the Company’s Advisory Board,” Aaron Keay, CEO and director of ABcann Global, stated in the…

ThursdayMay 04, 2017 1:25 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on May 4, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: NGTF 47.06% – News: Issues shareholder update DSGT 40.00% – News: Secures contract with Nicklaus-Palmer Golf Resort CDNA 29.89% – News: Advances toward CMS coverage for AlloSure NMUS 26.85% – News: Announces $20M Series E Preferred Stock Financing AGEN 16.96% – News: Posts Q1 2017 results and corporate update SQBG 14.79% – News: Posts Q1 2017 results; Enters agreement with QVC, Inc. AMMA 11.52% – News: Signs new fighters; Law Firm files class action…

ThursdayMay 04, 2017 1:25 pm

NetworkNewsBreaks – Aegis Capital Maintains ‘Buy’ Rating on Concert Pharmaceuticals, Inc. (NASDAQ: CNCE)

Aegis Capital has reiterated a ‘Buy’ rating and issued a price target of $25 on shares of Concert Pharmaceuticals, Inc.’s (NASDAQ: CNCE) stock. The news follows the company’s recently reported financial results for the first quarter of 2017, including revenue of $20,000 for the quarter. The analyst noted that because Concert is a clinical stage development company, the firm focuses less on the quarterly financials and more on events surrounding clinical trials and deal announcements. During the first quarter, Concert entered an asset purchase agreement with Vertex Pharmaceuticals (NASDAQ: VRTX) for CTP-656. Per the agreement, Vertex will pay Concert up…

ThursdayMay 04, 2017 1:23 pm

NetworkNewsBreaks – Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) Reiterated with ‘Buy’ at Aegis Capital

Aegis Capital has reiterated a ‘Buy’ rating and price target of $63 on Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) following the company’s recent financial results for the first quarter ended March 31, 2017. The company reported that cash, cash equivalents, and investments at the end of the quarter totaled $207.9 million. The analyst noted that because Aerie is a clinical stage development company, the firm is more focused on upcoming catalysts than quarterly financials. Catalysts for the company include the completion of the Rocket 4 trial; the upcoming Mercury 2 three-month efficacy and safety readout for Roclatan that is expected in…

ThursdayMay 04, 2017 1:20 pm

NetworkNewsBreaks – Aegis Capital Reiterates ‘Buy’ Rating on Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA)

Following Vanda Pharmaceuticals, Inc.’s (NASDAQ: VNDA) first quarter 2017 results, Aegis Capital has reiterated its ‘Buy’ rating and price target of $24 on shares of the company’s stock. The company reported net product sales of $37.4 million in the first quarter of 2017 and reaffirmed its net product sales guidance for 2017 of $165 million to $175 million. The Aegis analyst noted that the company has expanded its sales team for Fanapt®, which should drive growth in the third and fourth quarter of this year. Data from three trials that the analyst cited as catalysts for the year is also…

ThursdayMay 04, 2017 1:19 pm

NetworkNewsBreaks – Aegis Capital Issues ‘Buy’ Rating on Soligenix, Inc. (NASDAQ: SNGX)

Aegis Capital has issued a ‘Buy’ rating and price target of $7 on shares of Soligenix, Inc.’s (NASDAQ: SNGX) stock. The analyst cites the recent approval by the FDA to advance a pivotal phase 3 clinical trial evaluating SGX942 for the treatment of oral mucositis in head and neck cancer (HNC) patients being treated with chemoradiation (CRT). Soligenix plans to initiate this study in the second quarter of 2017. The analyst also noted the company has recently reached important milestones in its development of a vaccine against ricin poisoning, with several data presentations from animal models. For more information, visit…

ThursdayMay 04, 2017 8:58 am

NetworkNewsBreaks – Moxian, Inc. (NASDAQ: MOXC) Offers Intriguing Opportunity to Capitalize on Explosive Chinese Consumer Market Growth Projections

Understanding that an economy solely based on exports will ultimately implode, China has begun turning inward to expand its national economic drivers. With a population of almost 1.4 billion, China represents a huge new consumer market, and Moxian, Inc. (NASDAQ: MOXC) is poised to capitalize on the significant economic shift occurring in China and other parts of Asia by serving businesses that feed the demands of the new Chinese consumer. “With offices strategically located in China, Malaysia, and Hong Kong, Moxian provides small- and medium-sized businesses cutting edge turnkey solutions to attract and maintain customers. The company’s strategy is to…

ThursdayMay 04, 2017 8:56 am

NetworkNewsBreaks – GreeneStone Healthcare Corp. (GRST) Combating Devastating Effects of Substance Abuse on Florida’s Youth and Young Adults

Addiction is a chronic global problem with devastating effects for both youth and adults. For Floridians, the combination of rampant drug trafficking, widespread alcohol consumption, and the reputation for being a spring break party destination has made addiction a critical, statewide crisis—particularly for Florida’s youth. GreeneStone Healthcare Corp. (OTCQB: GRST) is working to help alleviate the problem of addiction by offering lifesaving addiction and rehabilitation treatment services to Floridians through its recently acquired Seastone Drug Rehab facility, located in Delray Beach, Florida. “The company, which offers addiction and rehabilitation treatment services, some of which include counseling, coaching, intervention, psychological assessment,…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks